MSTXMagnet Schools of Texas (educational association)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Biopharmaceutical company Mast Therapeutics (NYSE MKT: MSTX) reported on Tuesday the completion of its public offering of 29,090,910 units.
(NYSE: MSTX) vote in favour of the company's proposed merger with US-based pharmaceutical company Savara Inc.
(NYSE MKT: MSTX), a clinical-stage biopharmaceutical company, has reported its financial results for the nine months ended 30 September 2014, it was reported on Friday.